Ticagrelor unique properties have sparked interest in its potential applications beyond ACS and coronary interventions. Ongoing research is evaluating its use in other high-risk populations, such as patients with peripheral arterial disease, ischemic stroke, and diabetes mellitus. Preliminary data suggests promising outcomes in these populations, heralding a new era in Ticagrelor's clinical utility.
As the field of cardiovascular medicine continues to evolve, Ticagrelor holds great promise for further advancements. Researchers are investigating combination therapies, such as dual antiplatelet therapy and anticoagulant combinations, to maximize the benefits of Ticagrelor in select patient populations. Additionally, ongoing studies explore the role of Ticagrelor in other thrombotic conditions, including venous thromboembolism and acute ischemic stroke, broadening its potential impact on overall cardiovascular care.
Read More- https://cmiblogdailydose.blogspot.com/2023/05/ticagrelor-aid-blood-to-flow-easily.html
